Although the jab has been tested on prostate tumours, they believe it could work on a range of other deadly cancers including breast, lung and pancreatic cancer.
Advertisement
Unlike a conventional vaccine which is given to prevent infection with a virus or bacteria, the new treatment is used after someone has contracted cancer.
Prof Alan Melcher, from the University of Leeds, who co-led the research, said clinical trials could be underway within ‘a few years’ and that the same technique could work for a host of cancers.
Join the conversation as a VIP Member